Oxandrolone ( DrugBank: Oxandrolone )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
211	左心低形成症候群	1
285	ファンコニ貧血	1

211. 左心低形成症候群

臨床試験数 : 22 / 薬物数 : 29 - (DrugBank : 9) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 14

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04090697 (ClinicalTrials.gov)	December 20, 2019	4/4/2019	Use of Oxandrolone to Promote Growth in Infants With HLHS	Use of Oxandroloneto Promote Growth in Infants With Hypoplastic Left Heart Syndrome: A Phase I/II Pi ...	Hypoplastic Left Heart;Congenital Heart Disease	Drug: Oxandrolone	HealthCore-NERI	NULL	Recruiting	N/A	14 Days	All	100	Phase 1/Phase 2	United States;Canada

臨床試験数 : 62 / 薬物数 : 93 - (DrugBank : 30) / 標的遺伝子数 : 30 - 標的パスウェイ数 : 144

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00243399 (ClinicalTrials.gov)	July 2004	20/10/2005	Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia	A Pilot Trial of Oxandrolonefor the Treatment of Bone Marrow Aplasia in Patients With Fanconi Anemia ...	Fanconi Anemia	Drug: Oxandrolone	Children's Hospital Medical Center, Cincinnati	FDA Office of Orphan Products Development	Completed	N/A	N/A	Both	10	Phase 1	United States